We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $526M
1-Year Est. Return 22.2%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+22.2%
3 Year Est. Return
+74.69%
5 Year Est. Return
+94.09%
10 Year Est. Return
+300.66%
AUM
$278M
AUM Growth
+$30.9M
Cap. Flow
+$9.13M
Cap. Flow %
3.28%
Top 10 Hldgs %
20.03%
Holding
601
New
41
Increased
171
Reduced
75
Closed
21

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.53M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$1.1M
3
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$600K
4
PNRA
Panera Bread Co
PNRA
+$576K
5
CPRI icon
Capri Holdings
CPRI
+$536K

Top Sells

Rank Stock Value
1
ZOLT
ZOLTEK COMPANIES INC
ZOLT
+$251K
2
NE
Noble Corporation
NE
+$244K
3
EXC icon
Exelon
EXC
+$230K
4
TFX icon
Teleflex
TFX
+$229K
5
PXD
Pioneer Natural Resource Co.
PXD
+$173K

Sector Composition

Rank Sector Weight
1 Healthcare 16.93%
2 Energy 12.95%
3 Industrials 11.94%
4 Financials 11.15%
5 Technology 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$647B
$13.6M 4.89%
134,152
+3,279
+3% +$303K
GE icon
2
GE Aerospace
GE
$377B
$5.75M 2.07%
42,774
+690
+2% +$86.9K
DHR icon
3
Danaher
DHR
$140B
$5.62M 2.02%
108,280
+780
+0.7% +$38.4K
MA icon
4
Mastercard
MA
$494B
$5.43M 1.95%
64,970
-500
-0.8% -$37.1K
IBM icon
5
IBM
IBM
$207B
$4.95M 1.78%
27,606
-502
-2% -$86.6K
TMO icon
6
Thermo Fisher Scientific
TMO
$214B
$4.57M 1.64%
41,014
– –
CVX icon
7
Chevron
CVX
$380B
$4.37M 1.57%
34,964
+643
+2% +$77.7K
PG icon
8
Procter & Gamble
PG
$355B
$4.35M 1.57%
53,439
+820
+2% +$66.8K
ECL icon
9
Ecolab
ECL
$79.4B
$3.8M 1.37%
36,425
-999
-3% -$104K
HSIC icon
10
Henry Schein
HSIC
$9.69B
$3.25M 1.17%
72,616
-510
-0.7% -$22.3K
IGSB icon
11
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$3.09M 1.11%
58,596
+11,386
+24% +$600K
QCOM icon
12
Qualcomm
QCOM
$176B
$3.01M 1.08%
40,598
+1,801
+5% +$127K
EMR icon
13
Emerson Electric
EMR
$84.5B
$3.01M 1.08%
42,874
+390
+0.9% +$26.1K
PFE icon
14
Pfizer
PFE
$144B
$3.01M 1.08%
103,517
+334
+0.3% +$9.72K
ABBV icon
15
AbbVie
ABBV
$467B
$3.01M 1.08%
56,951
+233
+0.4% +$11.5K
BAC icon
16
Bank of America
BAC
$436B
$2.99M 1.08%
192,038
-5,820
-3% -$86.3K
ITW icon
17
Illinois Tool Works
ITW
$85.6B
$2.99M 1.08%
35,516
+3
+0% +$237
MRK icon
18
Merck
MRK
$331B
$2.85M 1.02%
59,613
+596
+1% +$27.2K
VFC icon
19
VF Corp
VFC
$6.93B
$2.78M 1%
47,365
+340
+0.7% +$17.7K
AAPL icon
20
Apple
AAPL
$4.97T
$2.65M 0.95%
132,076
+6,300
+5% +$119K
JNJ icon
21
Johnson & Johnson
JNJ
$656B
$2.62M 0.94%
28,654
+1,302
+5% +$120K
BMY icon
22
Bristol-Myers Squibb
BMY
$132B
$2.54M 0.91%
47,742
-141
-0.3% -$7.18K
SYK icon
23
Stryker
SYK
$134B
$2.41M 0.87%
32,095
– –
IGIB icon
24
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$2.4M 0.86%
44,506
+4,918
+12% +$266K
JPM icon
25
JPMorgan Chase
JPM
$942B
$2.39M 0.86%
40,922
+12
+0% +$657
1
2 3 4 5

Similar funds

OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $525M AUM 16.61% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return
CM
Conifer Management New York $524M AUM 14.11% 1-Year Est. Return
ETS
ESL Trust Services Rochester, New York $524M AUM 17.18% 1-Year Est. Return

Duncker Streett & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Duncker Streett & Co held 601 positions worth $278M, up 12% from $247M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Duncker Streett & Co deployed $9.13M of net new capital in Q4 2013, opening 41 new positions and adding to 171 existing holdings. Its largest new stake was Allergan plc: 9,790 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was ZOLTEK COMPANIES INC, an estimated $251K trimmed.

  • Duncker Streett & Co's largest Q4 2013 buy was Allergan plc: 9,790 shares worth $1.65M.
  • Duncker Streett & Co added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2013, an estimated $600K increase.
  • Duncker Streett & Co's biggest Q4 2013 reduction was ZOLTEK COMPANIES INC, cutting an estimated $251K.
  • Duncker Streett & Co fully exited Noble Corporation in Q4 2013, selling an estimated $244K.
  • Duncker Streett & Co's ten largest holdings make up 20% of its $278M portfolio in Q4 2013.
  • Duncker Streett & Co opened 41 new positions and closed 21 in Q4 2013.
  • Duncker Streett & Co's portfolio value rose 12% quarter-over-quarter to $278M.

Based on Duncker Streett & Co's 13F filing for Q4 2013, filed 22 Jan 2014.